GLP-1 Receptor Agonist | Weight Loss, Appetite Suppression & Glycaemic Control | For Research Use Only

Semaglutide is a cutting-edge GLP-1 receptor agonist used in metabolic research focused on obesity, type 2 diabetes, and insulin resistance. By mimicking the natural incretin hormone GLP-1, Semaglutide enhances insulin secretion, suppresses glucagon release, delays gastric emptying, and reduces appetite, leading to significant weight reduction and improved blood sugar control in research models.

Its long half-life makes it ideal for once-weekly administration in studies requiring sustained metabolic modulation.

🔍 Key Features

• Mimics Endogenous GLP-1 Activity

• Supports Appetite Reduction & Caloric Deficit

• Improves Glycaemic Control & Insulin Sensitivity

• Research Applications in Obesity, Diabetes & PCOS

• Ideal for Long-Term Metabolic Health Studies

⚙️ Compound Details

• Compound Name: Semaglutide

• CAS Number: 910463-68-2

• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉

• Molecular Weight: ~4113.58 g/mol

• Purity: ≥ 98% (HPLC Verified)

• Form: Lyophilised powder

• Unit Size: 10mg per vial

🧊 Storage & Handling

• Storage (lyophilised): Store at –20°C, protected from light and moisture

• Reconstitution: Reconstitute with sterile bacteriostatic water

• Post-Reconstitution: Store at 2–8°C and use within 10 days

• Avoid: Repeated freeze-thaw cycles, heat, and light exposure

⚠️ For Research Use Only

Semaglutide – 10mg is supplied strictly for laboratory and scientific research. It is not intended for human use, medical treatment, or diagnosis. To be handled by qualified professionals only.